Elutia is a pioneering medical company based in Roswell, GA, that specializes in drug-eluting biomaterials for medical device implantation and soft tissue reconstruction. Their proprietary technology aims to address post-surgical complications and improve patient outcomes by promoting implant stability, supporting healthy wound healing, and mitigating fibrotic responses. With a focus on humanizing medicine, Elutia's drug-eluting biomaterial platforms are at the forefront of medical innovation, ensuring patients can thrive without compromise.
Elutia offers two main products: CanGaroo, an acellular device envelope for pacemakers, defibrillators, and neurostimulators, and SimpliDerm, a human acellular dermal matrix for soft tissue reconstruction. Both products provide robust and easy-to-use constructs that optimize stability, mitigate device migration and erosion, and promote wound healing. By eliminating the challenges of post-surgical complications, Elutia's drug-eluting biomaterials are revolutionizing patient care and improving the success of medical device implantation and soft tissue repair procedures.
Generated from the website